Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.650
-0.200 (-10.81%)
At close: Mar 28, 2025, 4:00 PM
1.690
+0.040 (2.42%)
Pre-market: Mar 31, 2025, 8:33 AM EDT
Annovis Bio Stock Forecast
ANVS's stock price has decreased by -86.28% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Annovis Bio stock have an average target of 37, with a low estimate of 25 and a high estimate of 67. The average target predicts an increase of 2,142.42% from the current stock price of 1.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 11, 2024.
Analyst Ratings
The average analyst rating for Annovis Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +1,172.73% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,718.18% | Nov 11, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $25 | Hold → Strong Buy | Upgrades | $25 | +1,415.15% | Oct 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,718.18% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
n/a
from 242.60M
Revenue Next Year
n/a
EPS This Year
-2.00
from -2.31
EPS Next Year
-1.96
from -2.00
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 34.5M | 632.5M | ||
| Avg | n/a | 6.7M | 157.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 9,342.0% | ||
| Avg | - | - | 2,256.6% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.85 | -0.32 | -0.59 | ||
| Avg | -2.00 | -1.96 | -0.57 | ||
| Low | -2.86 | -2.72 | -0.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.